Abiraterone Acetate
CAS 154229-19-3 20 FDA-DMF suppliersSmall Molecule
Overview
Abiraterone Acetate is a steroidal compound used in the treatment of prostate cancer. It works by inhibiting the enzyme CYP17A1, which is involved in androgen production.
API suppliers (1)
Suppliers of Abiraterone Acetate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- Cipla USA, Inc.USA
Therapeutic areas
OncologyEndocrine Therapy
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.